Antibiotic Resistance in COVID-19 with Bacterial Infection: Laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia

References

• Pierce J, Stevens MP. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications. Int J Infect Dis. 2021;113:103–108. doi:10.1016/j.ijid.2021.10.001
   PubMed Web of Science ®Google Scholar
• Pusat Informasi & Koordinasi Provinsi Jawa Barat. Sebaran kasus Covid-19 di jawa barat. Pusat informasi & koordinasi provinsi jawa barat; 2022. Available from: https://pikobar.jabarprov.go.id/distribution-case. Accessed January 13, 2022.
   Google Scholar
• Lv Z, Cheng S, Le J, et al. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect. 2020;22(4–5):195–199. doi:10.1016/j.micinf.2020.05.007
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Ghosh S, Bornman C, Zafer MM. Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand? J Infect Public Health. 2021;14(5):555–560. doi:10.1016/j.jiph.2021.02.011
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi:10.1016/j.cmi.2020.07.041
   PubMed Web of Science ®Google Scholar
• Nori P, Cowman K, Chen V, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42(1):84–88. doi:10.1017/ice.2020.368
   PubMed Web of Science ®Google Scholar
• Owoicho O, Tapela K, Djomkam Zune AL, Nghochuzie NN, Isawumi A, Mosi L. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Future Microbiol. 2021;16(12):919–925. doi:10.2217/fmb-2021-0008
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Action Plan on Antimicrobial Resistance. World Health Organization; 2015.
   Google Scholar
• Kementerian Kesehatan RI. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19); 2020.
   Google Scholar
• Vandepitte J; World Health Organization. Basic Laboratory Procedures in Clinical Bacteriology. 2nd ed. World Health Organization; 2003.
   Google Scholar
• World Health Organization. Diagnostic Stewardship: A Guide to Implementation in Antimicrobial Resistance Surveillance Sites. World Health Organization; 2016.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Supplement M100. 30th ed. Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Vong S, Anciaux A, Hulth A, et al. Using information technology to improve surveillance of antimicrobial resistance in South East Asia. BMJ. 2017:j3781. doi:10.1136/bmj.j3781
   Web of Science ®Google Scholar
• Shah AS, Karunaratne K, Shakya G, et al. Strengthening laboratory surveillance of antimicrobial resistance in South East Asia. BMJ. 2017:j3474. doi:10.1136/bmj.j3474
   Web of Science ®Google Scholar
• World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021. World Health Organization; 2021.
   Google Scholar
• Clinical Laboratory Standard Institute. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline. 3rd ed. Clinical and Laboratory Standards Institute; 2009.
   Google Scholar
• Metlay JP, Waterer GW, Long AC, et al.; Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi:10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Indonesian Ministry of Health. Peraturan Menteri Kesehatan Republik Indonesia Nomor 8 Tahun 2015 Tentang Program Pengendalian Resistensi Antimikroba di Rumah Sakit; 2015.
   Google Scholar
• Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. doi:10.1016/j.virusres.2020.198005
   PubMed Web of Science ®Google Scholar
• O’Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect. 2021;27(12):1772–1776. doi:10.1016/j.cmi.2021.06.001
   Web of Science ®Google Scholar
• Hernández-Terán A, Mejía-Nepomuceno F, Herrera MT, et al. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes. Sci Rep. 2021;11(1):21297. doi:10.1038/s41598-021-00851-0
   PubMed Web of Science ®Google Scholar
• Naqvi AAT, Fatima K, Mohammad T, et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta. 2020;1866(10):165878. doi:10.1016/j.bbadis.2020.165878
   PubMed Web of Science ®Google Scholar
• Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395–1399. doi:10.1016/j.cmi.2020.06.025
   PubMed Web of Science ®Google Scholar
• Lee S, Koh JS, Kim YJ, et al. Secondary infection among hospitalized COVID‐19 patients: a retrospective cohort study in a tertiary care setting. Respirology. 2021;26(3):277–278. doi:10.1111/resp.13992
   Web of Science ®Google Scholar
• Townsend L, Hughes G, Kerr C, et al. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC Antimicrob Resist. 2020;2(3):dlaa071. doi:10.1093/jacamr/dlaa071
   PubMedGoogle Scholar
• Santoso P, Sung M, Hartantri Y, et al. MDR pathogens organisms as risk factor of mortality in secondary pulmonary bacterial infections among COVID-19 patients: observational studies in two referral hospitals in West Java, Indonesia. Int J Gen Med. 2022;15:4741–4751. doi:10.2147/IJGM.S359959
   PubMed Web of Science ®Google Scholar
• Limato R, Nelwan EJ, Mudia M, et al. A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals. JAC Antimicrob Resist. 2021;3(2):dlab047. doi:10.1093/jacamr/dlab047
   Google Scholar
• Otto M. Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and. BioEssays. 2013;35(1):4–11. doi:10.1002/bies.201200112
   PubMed Web of Science ®Google Scholar
• Chin TL, McNulty C, Beck C, MacGowan A. Antimicrobial resistance surveillance in urinary tract infections in primary care. J Antimicrob Chemother. 2016;71(10):2723–2728. doi:10.1093/jac/dkw223
   Web of Science ®Google Scholar
• Laupland KB, Ross T, Pitout JDD, Church DL, Gregson DB. Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin Invest Med. 2007;30(4):E159–E166. doi:10.25011/cim.v30i4.1777
   Web of Science ®Google Scholar
• Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect. 2009;137(12):1665–1673. doi:10.1017/S0950268809990100
   Web of Science ®Google Scholar